Empirical Asset Management, LLC
Source: SEC Form 13F · as of Mar 2026Empirical Asset Management, LLC holds 20 biotech & pharma companies tracked by BioSniper, totaling $16.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$16.1M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 3,409 | $3.1M |
| MRKMerck & Co., Inc. | 16,535 | $2.0M |
| SUNSUNSET ISLAND GROUP | 28,020 | $1.8M |
| GILDGILEAD SCIENCES, INC. | 11,184 | $1.6M |
| MCKMcKesson Corporation | 1,540 | $1.3M |
| JNJJOHNSON & JOHNSON | 5,384 | $1.3M |
| ABBVAbbVie Inc. | 3,421 | $744K |
| INCYIncyte Corp. | 7,373 | $694K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,450 | $663K |
| MEDPMedpace Holdings Inc. | 1,176 | $565K |
| AMGNAMGEN INC | 1,522 | $535K |
| ABTABBOTT LABORATORIES | 2,984 | $306K |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 1,508 | $260K |
| PFEPFIZER INC | 8,908 | $250K |
| PBIPROVENTION BIO, INC. | 21,368 | $236K |
| BMYBRISTOL MYERS SQUIBB CO | 3,364 | $204K |
| CNTACentessa Pharmaceuticals plc | 5,083 | $202K |
| BVSBioventus Inc. | 17,608 | $161K |
| CRONCronos Group Inc. | 25,000 | $63K |
| AKBAAkebia Therapeutics, Inc. | 35,000 | $49K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.